JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anand-Apte, B.
Right arrow Articles by Symons, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anand-Apte, B.
Right arrow Articles by Symons, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 49, Issue of December 5, 1997 pp. 30688-30692

Platelet-derived Growth Factor and Fibronectin-stimulated Migration Are Differentially Regulated by the Rac and Extracellular Signal-regulated Kinase Pathways*

(Received for publication, June 25, 1997, and in revised form, September 25, 1997)

Bela Anand-Apte Dagger §, Bruce R. Zetter Dagger , Akila Viswanathan Dagger , Rong-Guo Qiu , Jing Chen , Rosamaria Ruggieri and Marc Symons par

From the Dagger  Departments of Surgery and Cell Biology, Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115 and  ONYX Pharmaceuticals, Richmond, California 94806

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

Directed cell migration is essential for a variety of important biological processes ranging from development and angiogenesis to metastasis. Ras plays a pivotal role in the signaling cascade that governs chemotaxis of fibroblasts toward platelet-derived growth factor-BB (PDGF-BB). Ras activates multiple downstream pathways, which include the extracellular signal-regulated kinase (ERK), Rac, and Ral signaling cascades. We therefore investigated the role of the Rac and ERK pathways in cell migration. We showed that migration of fibroblasts toward PDGF-BB is inhibited by expression of dominant negative Asn-17 Rac1. Blocking of the ERK pathway by either expression of dominant negative Ala-218/Ala-222-mitogen-activated protein kinase kinase (A218/A222-MEK1) or by a MEK-specific inhibitor did not inhibit migration toward PDGF-BB. In contrast, migration toward soluble fibronectin was suppressed by inhibition of the ERK pathway but not by Asn-17 Rac1 expression. These results indicate that directed cell migration mediated by different receptor classes in response to different ligands differentially utilizes the Rac and ERK pathways and suggest that Rac might play a critical role in pathological processes such as angiogenesis and metastasis.


INTRODUCTION

Directed cell migration or chemotaxis is a critical feature of several physiological and pathological processes, including development, wound healing, atherosclerosis, immunity, angiogenesis, and metastasis (1-4). Chemotaxis involves the sensing of a concentration gradient of chemoattractant, reorganization of the actin cytoskeleton, and subsequent movement toward the chemoattractant. Cytokine-induced reorganization of the actin cytoskeleton is mediated by members of the Rho family of GTP-binding proteins. Rho regulates stress fiber assembly, Rac controls lamellipodia formation, and Cdc42 directs the dynamics of filipodia (5-8).

We have shown previously that the GTP-binding protein Ras plays a central role in the signaling cascade that governs chemotaxis of fibroblasts toward PDGF-BB1 (9). However, the pathways downstream of Ras that control cell motility remain unknown. Ras activates several distinct effector pathways, including the ERK cascade, the pathway controlled by Rac, and the pathway initiated by RalGDS, the guanine nucleotide dissociation stimulator for RalA and -B, which are close relatives of Ras (10-17). Since Rac has been shown to control the formation of lamellipodia induced by Ras (5, 18), it is a likely candidate for regulating Ras-mediated directed migration. A possible role for Rac in directed migration is also suggested by observations showing that Ras- and growth factor-induced activation of Rac are mediated by phosphatidylinositol 3-kinase (17, 19), which in turn has been implicated in chemotaxis (20-22). In this study, therefore, we investigated the role of Rac in different types of cell migration: directed migration toward PDGF-BB and soluble fibronectin and random migration stimulated by lysophosphatidic acid (LPA).


EXPERIMENTAL PROCEDURES

Cell Lines

Derivatization, properties, and growth conditions of Asn-17 Rac1 (N17-Rac1)-expressing Rat1 fibroblasts have been previously described (12). ERK activation by 2.5 ng/ml PDGF-BB or 1 µg/ml LPA in these mutant Rac1-expressing lines is similar to that of control cells, indicating that the changes in cell migration stimulated by PDGF-BB and LPA are not a consequence of changes in expression level of the PDGF-beta and LPA receptors.

For the establishment of A218/A222-MEK1-expressing lines, Glu-tagged full-length A218/A222-MEK1 (kindly provided by S. Macdonald and E. Porfiri, ONYX) was subcloned as a BamHI-NotI fragment into the expression plasmid pAUCT. This is a pBR-based vector that contains the neomycin resistance gene under the control of the thymidine kinase promoter, the Tet repressor-VP16 fusion cDNA under the control of the cytomegalovirus promoter, and the Tet operator driving the expression of the gene of interest (kindly provided by A. Fattaey, ONYX). Rat 1 fibroblast lines expressing A218/A222-MEK1 or the pAUCT vector control were established after DNA transfection by selecting G418-resistant clones growing in the presence of tetracycline to maintain the expression of recombinant MEK1 mutant at low levels. Clones were maintained in high glucose (4.5 g/liter) Dulbecco's modified Eagle's medium, supplemented with 10% fetal bovine serum, 2 mM glutamine, 100 units of penicillin, and 2 µg/ml streptomycin, 400 µg/ml G418, and 2 µg/ml tetracycline and kept at 37 °C and 5% CO2. Prior to experimental analysis, induction of recombinant Rac and MEK mutants was achieved by removing tetracycline for 24 h.

Expression levels of the Myc-tagged Rac mutants were obtained by immunoblotting using the 9E10 monoclonal antibody as in Ref. 23. Expression levels of the Glu-Glu-tagged MEK1 mutant were determined using an anti-Glu-Glu monoclonal antibody (24).

Kinase Assays

A218/A222-MEK1 expression was induced by removal of tetracycline for 24 h. Subsequently, cells were starved from serum for 18 h and induced with 10 nM epidermal growth factor for various periods of time. Cells were lysed in 20 mM Tris-HCl, pH 8.0, 137 mM NaCl, 1 mM EGTA, 1% Triton X-100, 10% glycerol, 1.5 mM MgCl2, 1 mM sodium vanadate, 1 mM Pefabloc, 20 µM leupeptin, 10 µg/ml aprotinin, and 50 mM NaF. Cleared lysates were incubated for 2 h at 4 °C with anti-ERK1 E1.2 crude serum and protein A-Sepharose. The beads were washed twice with lysis buffer and once with kinase buffer (30 mM Tris-HCl, pH 8.0, 20 mM MgCl2, and 2 mM MnCl2). The kinase reaction was initiated by adding 30 µl of kinase buffer (10 µM cold ATP, 2.5 µCi of [gamma -32P]ATP, and 7 µg of myelin basic protein) to the beads. After incubation for 30 min at 30 °C, reactions were stopped by adding sample buffer. Phosphorylated myelin basic protein was resolved on 14% SDS-PAGE and revealed by autoradiography.

Cell Migration Assays

Cell migration through collagen-coated filters was assayed as described previously (9). Cell binding to the collagen-coated filters of the various lines and control cells was determined at various times after incubation in the chemotaxis chamber. Nonadherent cells were washed off with phosphate-buffered saline, and adherent cells were counted under the microscope. Statistical analysis (two sample t test) was performed on the values for stimulated migration corrected for background migration (in the absence of stimulus).

Quantification of Growth Factor-induced Ruffling

Serum-starved cells were transferred to bicarbonate-free medium and mounted in a homemade observation chamber. Cell behavior was followed by means of video time lapse microscopy. Video frames were collected every 10 s with a Hamamatsu C2400 camera mounted on a Zeiss Axiovert 100TV inverted microscope provided with a × 40 Plan-NeoFluor NA 0.75 objective. Images were stored on a Panasonic TQ 2028F optical memory disk recorder. The number of ruffles per cell larger than 10 µm was determined at 2-min time intervals.


RESULTS

Rac Is Essential for Directed Migration toward PDGF-BB and Random Migration Stimulated by LPA

To investigate the function of Rac in cell migration, we employed Rat1 fibroblast lines expressing N17-Rac1 (12). We first characterized the migratory response of control Rat1 fibroblasts toward PDGF-BB, using a multiwell Boyden chamber assay (25). This assay measures the movement of cells across a porous membrane in response to a concentration gradient of a chemoattractant and has been shown previously to provide quantitative measurement of lymphocyte, endothelial cell, and tumor cell motility in response to a variety of physiological effectors. Control vector-transfected cells showed optimal migration toward a gradient generated by concentrations of 2.5-5 ng/ml PDGF-BB in the bottom well. Checkerboard analysis in which the amount of attractant was varied in both the top and bottom wells of the Boyden chamber indicated that the Rat1 fibroblasts display predominantly directional motility (chemotaxis) toward a PDGF-BB gradient, with a minor component attributed to an increase in random motility (data not shown). Relative to vector control cells, the three independent clones of Rat1 fibroblasts expressing N17-Rac1 tested were strongly inhibited in their migration toward PDGF-BB (p < 0.0005), whereas their basal unstimulated motility was not altered (Fig. 1a). These results indicate that Rac is a key element in the signaling pathway involved in directional migration induced by PDGF-BB. Basal cell movement, in contrast, does not depend on Rac.


Fig. 1. N17-Rac1 inhibits motility stimulated by PDGF-BB and LPA but not by fibronectin. a, directed migration of N17-Rac1-expressing Rat1 fibroblasts toward PDGF-BB. Filled bars, no chemoattractant; empty bars, 2.5 ng/ml PDGF-BB. b, migration of N17-Rac1-expressing Rat1 fibroblasts stimulated by LPA. Filled bars, no stimulus; empty bars, 1 µg/ml LPA. c, directed migration of N17-Rac1-expressing Rat1 fibroblasts toward soluble fibronectin. Filled bars, no chemoattractant; empty bars, 1 µg/ml fibronectin. Values shown indicate the number of cells migrating for a single well. Error bars indicate the S.E. of four wells. The results shown are representative of three independent experiments. d, Western blots showing N17-Rac1 expression levels in the Rat1 fibroblast lines used. Cell line 5-8 is a tetracycline-sensitive transactivator expressing vector control line (12).

[View Larger Version of this Image (15K GIF file)]


To further study the role of Rac in the regulation of cell motility, we investigated the response of the lines expressing mutant Rac proteins to LPA, a ligand that activates a G protein-coupled receptor (26). Checkerboard analysis demonstrated that LPA stimulates random, nondirectional migration (chemokinesis) in contrast to PDGF-BB, which stimulates directed cell migration. Here again, Rat1 fibroblasts expressing N17-Rac1 showed a strong reduction in LPA-stimulated migration (p < 0.0005) (Fig. 1b), indicating that Rac also plays an essential role in a signaling pathway utilized by LPA to control cell motility. Together with the previous data, these results also indicate that both random and directed stimulated cell motility are Rac-dependent and that motility signaling pathways triggered by tyrosine kinase and G protein-coupled receptors both employ Rac as a mediator.

To test whether the Rac pathway controls cell locomotion stimulated by other factors, we studied directed migration toward soluble fibronectin (FN), an integrin-mediated response. We previously showed that FN-stimulated migration is independent of Ras activity (9). At this moment it is not clear, however, whether migration toward soluble FN is chemotactic or haptotactic (migration guided by a gradient of increasing substrate adhesiveness).

Migration toward FN was not significantly inhibited by expression of N17-Rac (Fig. 1c). This indicates that, in contrast to motility stimulated by the growth factors PDGF-BB and LPA, Rac activity is not essential for migration toward fibronectin. These observations also further differentiate the motility pathway stimulated by fibronectin from those activated by the growth factors PDGF and LPA.

Inhibition of the ERK Pathway Impairs Directed Migration toward Soluble FN, but Not toward PDGF-BB

In addition to activating Rac, Ras also stimulates the ERK pathway, which is required for cell proliferation and transformation (11). The potential role of the ERK cascade in the regulation of cell motility is not yet clear, however. To study whether activation of the ERK pathway is necessary for cell migration, we used Rat1 fibroblast lines expressing dominant-negative A218/A222-MEK1 (11) from a tetracycline-repressible promotor (27). Although these lines showed greatly diminished ERK activation in response to growth factors (up to 90% inhibition of ERK activation for the line shown in Fig. 2), migration toward PDGF-BB was unaltered (Fig. 2a). In addition, although LPA stimulates ERK activity in a Ras-dependent fashion (28), A218/A222-MEK1 expressing lines did not show any inhibition in LPA-stimulated motility (Fig. 2b). Thus, Rac controls PDGF- and LPA-stimulated motility independently of the ERK pathway.


Fig. 2. A218/A222-MEK1 selectively inhibits directed migration toward soluble fibronectin. a, migration of A218/A222-MEK1-expressing Rat1 cells toward PDGF-BB (2.5 ng/ml). b, migration of A218/A222-MEK1-expressing Rat1 fibroblasts stimulated by LPA (1 µg/ml). c, directed migration of A218/A222-MEK1-expressing Rat1 fibroblasts toward soluble fibronectin (1 µg/ml). Other conditions were as in Fig. 1. d, upper panel, anti-Glu-Glu Western blots showing A218/A222-MEK1 expression levels; lower panel, 32P incorporation into myelin basic protein phosphorylated by immunoprecipitated ERK1 from cells treated with 10 nM epidermal growth factor for 10 min.

[View Larger Version of this Image (15K GIF file)]


In contrast to the above results, A218/A222-MEK1-expressing lines were significantly inhibited in migration toward soluble fibronectin (p < 0.0005) (Fig. 2c). The inhibition of fibronectin-stimulated migration was not caused by decreased adhesion of the A218/A222-MEK1-expressing lines to the filter separating the two chambers. Indeed, adhesion to the Boyden chamber collagen-coated filter of all of the cell lines used in this study (including the lines expressing the various Rac mutants) was indistinguishable from those of controls, and adhesion was independent of the presence of growth factors or soluble fibronectin in the bottom chamber (data not shown).

We further tested the role of the ERK pathway in cell migration using PD98059, a MEK-specific inhibitor (29), to block MEK activation. PD98059 at a concentration of 10 µM, which inhibits growth factor activation of ERK by 50-60% in Rat1 fibroblasts (30), significantly inhibited migration of vector control lines toward FN (p < 0.0005) but did not affect migration stimulated by either PDGF-BB or LPA (Fig. 3, a-c). These results confirm that activation of the ERK pathway is necessary for migration toward soluble fibronectin, indicating a novel function for the ERK pathway in integrin-mediated cell migration.


Fig. 3. The MEK inhibitor PD98059 selectively inhibits directed migration toward soluble fibronectin. a, effect of 10 µM PD98059 on migration of Rat1 vector control cells toward PDGF-BB (2.5 ng/ml). b, effect of 10 µM PD98059 on migration of Rat1 vector control cells stimulated by 1 µg/ml LPA. c, effect of 10 µM PD98059 on migration of Rat1 vector control cells toward 1 µg/ml fibronectin. Other conditions were as in Fig. 1.

[View Larger Version of this Image (14K GIF file)]


Mechanism of Rac-mediated Migration

The control of cell migration by Rac might be expected to involve the regulation of lamellipodial dynamics, which has been shown to be controlled by Rac (5). We therefore quantified PDGF-induced ruffling in Rat1 fibroblasts expressing N17-Rac1 and controls (Fig. 4). PDGF-induced ruffling was strongly inhibited by expression of N17-Rac1 in Rat1 fibroblasts, in agreement with results obtained in other cell types (5, 19). However, LPA at concentrations up to 1 µg/ml did not induce any ruffling response in Rat1 fibroblasts (data not shown), in line with earlier observations in Swiss 3T3 fibroblasts (6). These findings suggest that Rac may regulate cell motility independently of its role in lamellipodia formation.


Fig. 4. PDGF-induced ruffling is inhibited in Rat1 fibroblasts expressing N17-Rac1. The number of ruffles per cell was determined at the maximum of the ruffling response caused by the indicated concentrations of PDGF-BB (see "Experimental Procedures"). Error bars indicate the S.E. of four fields of cells, comprising 7-10 cells each.

[View Larger Version of this Image (13K GIF file)]



DISCUSSION

Our data indicate that the Rac and ERK pathways mediate different types of migratory behavior, with the Rac pathway controlling motility stimulated by PDGF-BB and LPA and the ERK pathway controlling motility stimulated by FN (Fig. 5). Because Ras is essential for both PDGF- and LPA-stimulated motility (9), our results also indicate that the Rac and ERK pathways can differentially mediate signals that emanate from Ras. This is consistent with results obtained with Ras effector loop mutants, which indicated that membrane ruffling and ERK activation are mediated by distinct Ras effectors (17, 18). The recent observation that Ras activation of Rac is mediated by phosphatidylinositol 3-kinase, is also in line with previous findings that chemotaxis toward PDGF is phosphatidylinositol 3-kinase-dependent (20-22). Interestingly, Ras, phosphatidylinositol 3-kinase, and Rac have also been shown to be necessary for hepatocyte growth factor/scatter factor-induced dispersion of Madin-Darby canine kidney cells (31-33), indicating that this signaling cascade may be utilized in a variety of motile responses and may play an important role in mammalian development (34).


Fig. 5. The Rac and ERK pathways mediate different modes of migration. Rac regulates directed migration toward PDGF-BB and random migration stimulated by LPA. The downstream pathway utilized by Rac in the control of cell motility is likely to be distinct from the pathway involved in lamellipodia formation. Migration toward fibronectin depends on activation of the ERK pathway but is independent of Ras activation. The relationship between migration and transcription is still not understood.

[View Larger Version of this Image (14K GIF file)]


Adhesion to fibronectin has been shown to activate ERK and may be responsible for shape-dependent cell proliferation (35-37). Our results indicate an additional role for the ERK pathway in fibronectin-stimulated migration. These results are consistent with a recent report, which shows that activation of the ERK pathway is necessary for haptotaxis stimulated by a collagen gradient (38). We have previously shown that migration toward soluble fibronectin is Ras-independent (9). Whether Ras plays a role in integrin-induced activation of ERK still remains to be resolved, however (39, 40).

The mechanism by which Rac controls migration remains to be elucidated. The inhibition of LPA-stimulated motility by N17-Rac1 suggests that the role of Rac in cell migration could be independent of its function in the control of lamellipodia. Although this may come as a surprise, it is consistent with recent studies on actin filament dynamics and ultrastructure in locomoting heart fibroblasts, which showed that the rate of cell locomotion correlates with the flow of actin filaments in the cell body and not with that in lamellipodia (41). Therefore, in addition to regulating the formation of lamellipodia, Rac may control more subtle cytoskeletal features, which still remain to be defined. Rac could also regulate cell migration by inducing the expression of matrix-degrading proteases, since AP1 and PEA3, two elements that are implicated in the control of matrix metalloprotease expression (42), are both activated by Rac (43, 44). A similar mechanism might be used by the ERK pathway to control cell migration toward fibronectin. Alternatively, the ERK pathway could control migration toward FN via activation of myosin light chain kinase, as was shown to be the case for collagen-mediated haptotaxis (38).

The function of Rac in the regulation of directed cell migration is in line with the role of Tiam1, a Rac guanine nucleotide exchange factor, which facilitates cell invasion (45, 46). Furthermore, directed migration is a critical component in angiogenesis (4). Thus, the data presented in this paper suggest that Rac, in addition to its role in tumorigenicity (12, 13), may be an important signaling element in metastasis and angiogenesis.


FOOTNOTES

*   The research was supported by National Institutes of Health Grant CA37393 (to B. R. Z.) and was carried out with interactive support by Bayer Corp.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   Present address: Dept. of Cell Biology, Cleveland Clinic Research Institute, Cleveland, OH 44195.
par    To whom correspondence should be addressed: ONYX Pharmaceuticals, 3031 Research Dr., Richmond, CA 94806. Tel.: 510-262-8735; Fax: 510-222-9758; E-mail: msymons{at}onyx-pharm.com.
1   The abbreviations used are: PDGF, platelet-derived growth factor; LPA, lysophosphatidic acid; N17-Rac1, Asn-17 Rac1; ERK, extracellular signal-regulated kinase; A218/A222-MEK1, Ala-218/Ala-222-mitogen-activated protein kinase kinase.

ACKNOWLEDGEMENTS

We are grateful to S. Macdonald, E. Porfiri, and A. Fattaey for gifts of plasmids. We also thank J. Folkman and A. Balmain for critical reading of the manuscript.


REFERENCES

  1. Bornfeldt, K. E. (1996) Trends Cardiovasc. Med. 6, 143-151
  2. Wilkinson, P. C., and Haston, W. S. (1988) Methods Enzymol. 162, 3-16 [Medline] [Order article via Infotrieve]
  3. Zetter, B. R. (1990) N. Engl. J. Med. 322, 605-612 [Medline] [Order article via Infotrieve]
  4. Stokes, C. L., and Lauffenburger, D. A. (1991) J. Theor. Biol. 152, 377-403 [CrossRef][Medline] [Order article via Infotrieve]
  5. Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekman, D., and Hall, A. (1992) Cell 70, 401-410 [CrossRef][Medline] [Order article via Infotrieve]
  6. Ridley, A. J., and Hall, A. (1992) Cell 70, 389-399 [CrossRef][Medline] [Order article via Infotrieve]
  7. Nobes, C. D., and Hall, A. (1995) Cell 81, 53-62 [CrossRef][Medline] [Order article via Infotrieve]
  8. Kozma, R., Ahmed, S., Best, A., and Lim, L. (1995) Mol. Cell. Biol. 15, 1942-1952 [Abstract]
  9. Kundra, V., Anand-Apte, B., Feig, L. A., and Zetter, B. R. (1995) J. Cell Biol. 130, 725-731 [Abstract/Free Full Text]
  10. White, M. A., Nicolette, C., Minden, A., Polverino, A., Van Aelst, L., Karin, M., and Wigler, M. H. (1995) Cell 80, 533-541 [CrossRef][Medline] [Order article via Infotrieve]
  11. Cowley, S., Paterson, H., Kemp, P., and Marshall, C. J. (1994) Cell 77, 841-852 [CrossRef][Medline] [Order article via Infotrieve]
  12. Qiu, R.-G., Chen, J., Kirn, D., McCormick, F., and Symons, M. (1995) Nature 374, 457-459 [CrossRef][Medline] [Order article via Infotrieve]
  13. Khosravi-Far, R., Solski, P. A., Clark, G. J., Kinch, M. S., and Der, C. J. (1995) Mol. Cell. Biol. 15, 6443-6453 [Abstract]
  14. White, M. A., Vale, T., Camonis, J. H., Schaefer, E., and Wigler, M. H. (1996) J. Biol. Chem. 271, 16439-16442 [Abstract/Free Full Text]
  15. Urano, T., Emkey, R., and Feig, L. A. (1996) EMBO J. 15, 810-816 [Medline] [Order article via Infotrieve]
  16. Khosravi-Far, R., White, M. A., Westwick, J. K., Solski, P. A., Chrzanowska-Wodnicka, M., Van Aelst, L., Wigler, M. H., and Der, C. J. (1996) Mol. Cell. Biol. 16, 3923-3933 [Abstract]
  17. Rodriguez-Viciana, P., Warne, P. H., Khwaja, A., Marte, B. M., Darryl Pappin, D., Das, P., Waterfield, M. D., Ridley, A., and Downward, J. (1997) Cell 89, 457-467 [CrossRef][Medline] [Order article via Infotrieve]
  18. Joneson, T., White, M. A., Wigler, M. H., and Bar-Sagi, D. (1996) Science 271, 810-812 [Abstract]
  19. Hawkins, P. T., Eguinoa, A., Qiu, R.-Q., Stokoe, D., Cooke, F., Walters, R., Wennstrom, S., Claesson-Welsh, L., Evans, T., Symons, M., and Stephens, L. (1995) Curr. Biol. 5, 393-403 [CrossRef][Medline] [Order article via Infotrieve]
  20. Kundra, V., Escobedo, J. A., Kazlauskas, A., Kim, H. K., Rhee, S. G., Williams, L. T., and Zetter, B. R. (1994) Nature 367, 474-476 [CrossRef][Medline] [Order article via Infotrieve]
  21. Wennstrom, S., Siegbahn, A., Yokote, K., Arvidsson, A.-K., Heldin, C.-H., Mori, S., and Claesson-Welsh, L. (1994) Oncogene 9, 651-660 [Medline] [Order article via Infotrieve]
  22. Godwin, S. L., and Soltoff, S. P. (1997) J. Biol. Chem. 272, 11307-11312 [Abstract/Free Full Text]
  23. Qiu, R.-G., Abo, A., McCormick, F., and Symons, M. (1997) Mol. Cell. Biol. 17, 3449-3458 [Abstract]
  24. Grussenmeyer, T., Scheidtmann, K. E. K. H., Hutchinson, M. A., and Walter, G. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 7952 [Abstract/Free Full Text]
  25. Boyden, S. J. (1962) J. Exp. Med. 115, 453-466 [Abstract]
  26. Moolenaar, W. H. (1995) Curr. Opin. Cell Biol. 7, 203-210 [CrossRef][Medline] [Order article via Infotrieve]
  27. Gossen, M., and Bujard, H. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 5547-5551 [Abstract/Free Full Text]
  28. Cook, S. J., Rubinfeld, B., Albert, I., and McCormick, F. (1993) EMBO J. 12, 3475-3485 [Medline] [Order article via Infotrieve]
  29. Pang, L., Sawada, T., Decker, S. J., and Saltiel, A. R. (1995) J. Biol. Chem. 270, 13585-13588 [Abstract/Free Full Text]
  30. Cook, S. J., Beltman, J., Cadwallader, K. A., McMahon, M., and McCormick, F. (1997) J. Biol. Chem. 272, 13309-13319 [Abstract/Free Full Text]
  31. Hartmann, G., Weidner, K. M., Schwarz, H., and Birchmeier, W. (1994) J. Biol. Chem. 269, 21936-21939 [Abstract/Free Full Text]
  32. Royal, I., and Park, M. (1995) J. Biol. Chem. 270, 27780-27787 [Abstract/Free Full Text]
  33. Ridley, A. J., Comoglio, P. M., and Hall, A. (1995) Mol. Cell. Biol. 15, 1110-1122 [Abstract]
  34. Bronner-Fraser, M. (1995) Trends Genet. 11, 423-425 [CrossRef][Medline] [Order article via Infotrieve]
  35. Chen, Q., Kinch, M. S., Lin, T. H., Burridge, K., and Juliano, R. L. (1994) J. Biol. Chem. 269, 26602-26605 [Abstract/Free Full Text]
  36. Schlaepfer, D. D., Hanks, S. K., Hunter, T., and van der Geer, P. (1994) Nature 372, 786-791 [Medline] [Order article via Infotrieve]
  37. Zhu, X., and Assoian, R. K. (1995) Mol. Biol. Cell 6, 273-282 [Abstract]
  38. Klemke, R. L., Shuang, C., Giannini, A. L., Gallagher, P. J., de Lanerolle, P., and Cheresh, D. A. (1997) J. Cell Biol. 137, 481-492 [Abstract/Free Full Text]
  39. Clark, E. A., and Hynes, R. O. (1996) J. Biol. Chem. 271, 14814-14818 [Abstract/Free Full Text]
  40. Chen, Q., Lin, T. H., Der, C. J., and Juliano, R. L. (1996) J. Biol. Chem. 271, 18122-18127 [Abstract/Free Full Text]
  41. Cramer, L., Siebert, M., and Mithchison, T. J. (1997) J. Cell Biol. 136, 1287-1305 [Abstract/Free Full Text]
  42. Crawford, H. C., and Matrisian, L. M. (1996) Enzyme Protein 49, 20-37 [Medline] [Order article via Infotrieve]
  43. Minden, A., Lin, A., Claret, F.-X., Abo, A., and Karin, M. (1995) Cell 81, 1147-1157 [CrossRef][Medline] [Order article via Infotrieve]
  44. O'Hagan, R. C., Tozer, R. G., Symons, M., McCormick, F., and Hassell, J. A. (1996) Oncogene 13, 1323-1333 [Medline] [Order article via Infotrieve]
  45. Habets, G. G. M., Scholtes, E. H. M., Zuydgeest, D., van der Kammen, R. A., Stam, J. C., Berns, A., and Collard, J. G. (1994) Cell 77, 537-549 [CrossRef][Medline] [Order article via Infotrieve]
  46. Michiels, F., Habets, G. G. M., Stam, J. C., van der Kammen, R. A., and Collard, J. G. (1995) Nature 375, 338-340 [CrossRef][Medline] [Order article via Infotrieve]

Volume 272, Number 49, Issue of December 5, 1997 pp. 30688-30692
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
H. Jiang, S. Rhee, C.-H. Ho, and F. Grinnell
Distinguishing fibroblast promigratory and procontractile growth factor environments in 3-D collagen matrices
FASEB J, July 1, 2008; 22(7): 2151 - 2160.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
R. D. Lester, M. Jo, V. Montel, S. Takimoto, and S. L. Gonias
uPAR induces epithelial mesenchymal transition in hypoxic breast cancer cells
J. Cell Biol., July 24, 2007; 178(3): 425 - 436.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
J. Huang, J.-T. Liang, H.-C. Huang, T.-L. Shen, H.-Y. Chen, N.-Y. Lin, M.-I. Che, W.-C. Lin, and M.-C. Huang
{beta}1,4-N-Acetylgalactosaminyltransferase III Enhances Malignant Phenotypes of Colon Cancer Cells
Mol. Cancer Res., June 1, 2007; 5(6): 543 - 552.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
D. Gentilini, M. Busacca, S. Di Francesco, M. Vignali, P. Vigano, and A.M. Di Blasio
PI3K/Akt And ERK1/2 signalling pathways are involved in endometrial cell migration induced by 17{beta}-estradiol and growth factors
Mol. Hum. Reprod., May 1, 2007; 13(5): 317 - 322.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Pilquil, J. Dewald, A. Cherney, I. Gorshkova, G. Tigyi, D. English, V. Natarajan, and D. N. Brindley
Lipid Phosphate Phosphatase-1 Regulates Lysophosphatidate-induced Fibroblast Migration by Controlling Phospholipase D2-dependent Phosphatidate Generation
J. Biol. Chem., December 15, 2006; 281(50): 38418 - 38429.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. A. Luckashenak, R. L. Ryszkiewicz, K. D. Ramsey, and J. L. Clements
The Src Homology 2 Domain-Containing Leukocyte Protein of 76-kDa Adaptor Links Integrin Ligation with p44/42 MAPK Phosphorylation and Podosome Distribution in Murine Dendritic Cells
J. Immunol., October 15, 2006; 177(8): 5177 - 5185.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
N. Ahmed, S. Maines-Bandiera, M. A. Quinn, W. G. Unger, S. Dedhar, and N. Auersperg
Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium
Am J Physiol Cell Physiol, June 1, 2006; 290(6): C1532 - C1542.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
L. Vidali, F. Chen, G. Cicchetti, Y. Ohta, and D. J. Kwiatkowski
Rac1-null Mouse Embryonic Fibroblasts Are Motile and Respond to Platelet-derived Growth Factor
Mol. Biol. Cell, May 1, 2006; 17(5): 2377 - 2390.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Kappert, E. Caglayan, M. Huntgeburth, A. T. Baumer, J. Sparwel, M. Uebel, and S. Rosenkranz
17{beta}-Estradiol attenuates PDGF signaling in vascular smooth muscle cells at the postreceptor level
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H538 - H546.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Kobel, G. Pohl, W. D. Schmitt, S. Hauptmann, T.-L. Wang, and I.-M. Shih
Activation of Mitogen-Activated Protein Kinase Is Required for Migration and Invasion of Placental Site Trophoblastic Tumor
Am. J. Pathol., September 1, 2005; 167(3): 879 - 885.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y.-y. Chuang, N. L. Tran, N. Rusk, M. Nakada, M. E. Berens, and M. Symons
Role of Synaptojanin 2 in Glioma Cell Migration and Invasion
Cancer Res., November 15, 2004; 64(22): 8271 - 8275.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Sakata, F. Xiang, Z. Chen, Y. Kiriyama, C. N. Kamei, D. I. Simon, and M. T. Chin
Transcription Factor CHF1/Hey2 Regulates Neointimal Formation In Vivo and Vascular Smooth Muscle Proliferation and Migration In Vitro
Arterioscler. Thromb. Vasc. Biol., November 1, 2004; 24(11): 2069 - 2074.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Huang, K. Jacobson, and M. D. Schaller
MAP kinases and cell migration
J. Cell Sci., September 15, 2004; 117(20): 4619 - 4628.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Pola, M. G. Cattaneo, and L. M. Vicentini
Anti-migratory and Anti-invasive Effect of Somatostatin in Human Neuroblastoma Cells: INVOLVEMENT OF RAC AND MAP KINASE ACTIVITY
J. Biol. Chem., October 17, 2003; 278(42): 40601 - 40606.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. J. Sundberg, L. M. Galante, H. M. Bill, C. P. Mack, and J. M. Taylor
An Endogenous Inhibitor of Focal Adhesion Kinase Blocks Rac1/JNK but Not Ras/ERK-dependent Signaling in Vascular Smooth Muscle Cells
J. Biol. Chem., August 8, 2003; 278(32): 29783 - 29791.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. L. Doughman, A. J. Firestone, M. L. Wojtasiak, M. W. Bunce, and R. A. Anderson
Membrane Ruffling Requires Coordination between Type I{alpha} Phosphatidylinositol Phosphate Kinase and Rac Signaling
J. Biol. Chem., June 13, 2003; 278(25): 23036 - 23045.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. L. Menna, G. Skilton, F. C. Leskow, D. F. Alonso, D. E. Gomez, and M. G. Kazanietz
Inhibition of Aggressiveness of Metastatic Mouse Mammary Carcinoma Cells by the {beta}2-Chimaerin GAP Domain
Cancer Res., May 1, 2003; 63(9): 2284 - 2291.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. L. Allen, D. H. Teitelbaum, and K. Kurachi
Growth factor stimulation of matrix metalloproteinase expression and myoblast migration and invasion in vitro
Am J Physiol Cell Physiol, April 1, 2003; 284(4): C805 - C815.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. K. Sastry, P. D. Lyons, M. D. Schaller, and K. Burridge
PTP-PEST controls motility through regulation of Rac1
J. Cell Sci., November 15, 2002; 115(22): 4305 - 4316.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
G.C. Weston, I. Haviv, and P.A.W. Rogers
Microarray analysis of VEGF-responsive genes in myometrial endothelial cells
Mol. Hum. Reprod., September 1, 2002; 8(9): 855 - 863.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
N. Edme, J. Downward, J.-P. Thiery, and B. Boyer
Ras induces NBT-II epithelial cell scattering through the coordinate activities of Rac and MAPK pathways
J. Cell Sci., June 15, 2002; 115(12): 2591 - 2601.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. Lu, Y.-j. Xiao, L. M. Baudhuin, G. Hong, and Y. Xu
Role of ether-linked lysophosphatidic acids in ovarian cancer cells
J. Lipid Res., March 1, 2002; 43(3): 463 - 476.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
H. M. ROSENFELDT, J. P. HOBSON, M. MACEYKA, A. OLIVERA, V. E. NAVA, S. MILSTIEN, and S. SPIEGEL
EDG-1 links the PDGF receptor to Src and focal adhesion kinase activation leading to lamellipodia formation and cell migration
FASEB J, December 1, 2001; 15(14): 2649 - 2659.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Karasarides, B. Anand-Apte, and A. Wolfman
A Direct Interaction between Oncogenic Ha-Ras and Phosphatidylinositol 3-Kinase Is Not Required for Ha-Ras-dependent Transformation of Epithelial Cells
J. Biol. Chem., October 19, 2001; 276(43): 39755 - 39764.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. Oertel, A. Graness, L. Thim, F. Buhling, H. Kalbacher, and W. Hoffmann
Trefoil Factor Family-Peptides Promote Migration of Human Bronchial Epithelial Cells . Synergistic Effect with Epidermal Growth Factor
Am. J. Respir. Cell Mol. Biol., October 1, 2001; 25(4): 418 - 424.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. Ward, W. Wang, E. Woodhouse, I. Linnoila, L. Liotta, and K. Kelly
Signal Pathways Which Promote Invasion and Metastasis: Critical and Distinct Contributions of Extracellular Signal-Regulated Kinase and Ral-Specific Guanine Exchange Factor Pathways
Mol. Cell. Biol., September 1, 2001; 21(17): 5958 - 5969.
[Abstract] [Full Text] [PDF]